Literature DB >> 2990915

Specific binding of radioiodinated granulocyte-macrophage colony-stimulating factor to hemopoietic cells.

F Walker, A W Burgess.   

Abstract

The hemopoietic growth factor granulocyte-macrophage colony-stimulating factor, GM-CSF, specifically controls the production of granulocytes and macrophages. This report describes the binding of biologically-active 125I-labeled murine GM-CSF to a range of hemopoietic cells. Specific binding was restricted to murine cells and neither rat nor human bone marrow cells appeared to have surface receptors for 125I-labeled GM-CSF. 125I-Labeled GM-CSF only appeared to bind specifically to cells in the myelomonocytic lineage. The binding of 125I-labeled GM-CSF to both bone marrow cells and WEHI-3B(D+) was rapid (50% maximum binding was attained within 5 min at both 20 degrees C and 37 degrees C). Unlabeled GM-CSF was the only polypeptide hormone which completely inhibited the binding of 125I-labeled GM-CSF to bone marrow cells, however, multi-CSF (also called IL-3) and G-CSF partially reduced the binding of 125I-labeled GM-CSF to bone marrow cells. Interestingly, the binding of 125I-labeled GM-CSF to a myelomonocytic cell line, WEHI-3B(D+), was inhibited by unlabeled GM-CSF but not by multi-CSF or G-CSF. Scatchard analysis of the binding of 125I-labeled GM-CSF to WEHI-3B(D+) cells, bone marrow cells and peritoneal neutrophils indicated that there were two classes of binding sites: one of high affinity (Kd1 = 20 pM) and one of low affinity (Kd2 = 0.8-1.2 nM). Multi-CSF only inhibited the binding of 125I-labeled GM-CSF to the high affinity receptor on bone marrow cells: this inhibition appeared to be a result of down regulation or modification of the GM-CSF receptor.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990915      PMCID: PMC554282          DOI: 10.1002/j.1460-2075.1985.tb03721.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

2.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

3.  Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells.

Authors:  E R Stanley; P M Heard
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

4.  Production of colony-stimulating factor in mitogen-stimulated lymphocyte cultures.

Authors:  J W Parker; D Metcalf
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

5.  Tissue sources of bone marrow colony stimulating factor.

Authors:  J W Sheridan; E R Stanley
Journal:  J Cell Physiol       Date:  1971-12       Impact factor: 6.384

6.  A "proportion graph" method for measuring binding systems.

Authors:  E E Baulieu; J P Raynaud
Journal:  Eur J Biochem       Date:  1970-04

7.  Purification and properties of colony-stimulating factor from mouse lung-conditioned medium.

Authors:  A W Burgess; J Camakaris; D Metcalf
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

8.  Factors regulating macrophage production and growth: identity of colony-stimulating factor and macrophage growth factor.

Authors:  E R Stanley; M Cifone; P M Heard; V Defendi
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

9.  Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.

Authors:  P Ralph; J Prichard; M Cohn
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

10.  Purification of human erythropoietin.

Authors:  T Miyake; C K Kung; E Goldwasser
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

View more
  32 in total

1.  Purified murine granulocyte/macrophage progenitor cells express a high-affinity receptor for recombinant murine granulocyte/macrophage colony-stimulating factor.

Authors:  D E Williams; D C Bicknell; L S Park; J E Straneva; S Cooper; H E Broxmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  GM-CSF action in the CNS decreases food intake and body weight.

Authors:  Jacquelyn A Reed; Deborah J Clegg; Kathleen Blake Smith; Emeline G Tolod-Richer; Emily K Matter; Lara S Picard; Randy J Seeley
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

3.  Hematopoietic growth factors.

Authors:  C A Sieff
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

Review 4.  A (selective) history of Australian involvement in cytokine biology.

Authors:  Nicos A Nicola
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-30       Impact factor: 7.638

5.  Hematopoietic growth factors activate the tyrosine phosphorylation of distinct sets of proteins in interleukin-3-dependent murine cell lines.

Authors:  A O Morla; J Schreurs; A Miyajima; J Y Wang
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

6.  Abelson virus transformation of an interleukin 2-dependent antigen-specific T-cell line.

Authors:  W D Cook; B Fazekas de St Groth; J F Miller; H R MacDonald; R Gabathuler
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

7.  A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF.

Authors:  I Nishijima; T Nakahata; Y Hirabayashi; T Inoue; H Kurata; A Miyajima; N Hayashi; Y Iwakura; K Arai; T Yokota
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

8.  Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice.

Authors:  H E Broxmeyer; D E Williams; S Cooper; R K Shadduck; S Gillis; A Waheed; D L Urdal; D C Bicknell
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

9.  Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells.

Authors:  D J Hilton; N A Nicola; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF: immune phenomena or drug toxicity?

Authors:  G J Locker; I Simonitsch; R M Mader; E Warlamides; M F Gnant; R Jakesz; H Rainer; G G Steger
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.